Ulcerative colitis (UC) is a complex chronic inflammatory
disease
closely associated with gut homeostasis dysfunction. The previous
studies have shown that stachyose, a functional food additive, has
the potential to enhance gut health and alleviate UC symptoms. However,
the underlying mechanism of its effects remains unknown. In this study,
our findings showed that dietary supplements of stachyose had a significant
dose-dependent protective effect on colitis symptoms, regulation of
gut microbiota, and restoration of the Treg/Th17 cell balance in dextran
sulfate sodium (DSS) induced colitis mice. To further validate these
findings, we conducted fecal microbiota transplantation (FMT) to treat
DSS-induced colitis in mice. The results showed that microbiota from
stachyose-treated mice exhibited a superior therapeutic effect against
colitis and effectively regulated the Treg/Th17 cell balance in comparison
to the control group. Moreover, both stachyose supplementation and
FMT resulted in an increase in butyrate production and the activation
of PPARγ. However, this effect was partially attenuated by PPARγ
antagonist GW9662. These results suggested that stachyose alleviates
UC symptoms by modulating gut microbiota and activating PPARγ.
In conclusion, our work offers new insights into the benefical effects
of stachyose on UC and its potential role in modulating gut microbiota.